Clinical Trials for Mereo BioPharma

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mereo BioPharma

Clinical Trials (2)

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer

PHASE2Active, not recruiting

20 participants

Started: Mar 24, 2023 · Completed: Feb 8, 2026

1 condition2 sponsors1 location

Setrusumab vs Placebo for Osteogenesis Imperfecta

PHASE2/PHASE3Active, not recruiting

183 participants

Started: Feb 21, 2022 · Completed: Apr 30, 2027

1 condition2 sponsors44 locations